Market Capitalization (Millions $) |
5 |
Shares
Outstanding (Millions) |
90 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-180 |
Cash Flow (TTM) (Millions $) |
-213 |
Capital Exp. (TTM) (Millions $) |
5 |
Rubius Therapeutics Inc
Rubius Therapeutics Inc is a biotechnology company that focuses on developing novel cellular therapies for treating a wide range of diseases. The company utilizes its proprietary Red Cell Therapeutics platform, which involves genetically engineering red blood cells to deliver therapeutic proteins, antibodies, enzymes, or nucleotides directly to the body. This innovative approach aims to overcome limitations associated with conventional cell-based therapies and provide more effective and targeted treatments. Rubius Therapeutics is actively involved in research and clinical development of its therapeutic candidates, with a mission to revolutionize the way patients with various diseases are treated.
Company Address: c/o Verdolino & Lowey, P.C. Foxborough, 2035 MA
Company Phone Number: 543-1720 Stock Exchange / Ticker: NASDAQ RUBY
|